+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine



Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine



Journal of Medicinal Chemistry 39(19): 3694-3700



The monoamine oxidase B (MAO-B) substrate properties and distance measurements along the N1-C4 axis of 38 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives, including seven newly synthesized MPTP analogs, were used to define the maximum size that can be accommodated by the MAO-B active site. Only those compounds measuring less than 12 A displayed significant MAO-B substrate properties. The behavior of various 4-substituted-1-cyclopropyltetrahydropyridine analogs also is discussed in terms of this N1-C4 distance parameter in an effort to understand factors which contribute to their substrate vs inactivator properties. We conclude that this distance parameter will predict the majority of substrates vs nonsubstrates with this class of compound.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008194384

Download citation: RISBibTeXText

PMID: 8809158

DOI: 10.1021/jm9603882


Related references

Generation of reactive oxygen species during monoamine oxidase catalyzed oxidation of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. FASEB Journal 7(3-4): A697, 1993

Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B. Journal of Neurochemistry 45(4): 1049-1054, 1985

Studies on the Monoamine Oxidase (MAO)-Catalyzed Oxidation of Phenyl-Substituted 1-Methyl-4-phenoxy-1,2,3,6-tetrahydropyridine Derivatives: Factors Contributing to MAO-A and MAO-B Selectivity. Journal of Medicinal Chemistry 38(11): 1904-1910, 1995

Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal Of Neurochemistry. 62(5): 2012-2016, 1994

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-Mpdp+, the monoamine oxidase catalyzed oxidation product of the nitrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

Comparison of the effects of two 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine analogs 1 methyl 4 2 thienyl 1 2 3 6 tetrahydropyridine and 1 methyl 4 3 thienyl 1 2 3 6 tetrahydropyridine on monoamine oxidase in vitro and on dopamine in mouse brain. Journal of Pharmacology & Experimental Therapeutics 240(2): 415-420, 1987

Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Journal of Pharmacology and Experimental Therapeutics 240(2): 415-420, 1987

Chemical model studies on two proposed pathway for the monoamine oxidase-B catalyzed oxidation of 1,4-disubstituted tetrahydropyridine derivatives. Abstracts of Papers American Chemical Society 212(1-2): TOXI 10, 1996

Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Biological Chemistry 268(22): 16504-16512, 1993

Marked 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine induced dopaminergic neurotoxicity in black mice with high cerebral 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine monoamine oxidase b activity. Experientia 42(6): 700, 1986

Why is the rat immune to 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine toxicity comparative studies of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine effect on striatal dopamine and monoamine oxidase b in mice and rats. Neurology 36(4 Suppl. 1): 97, 1986

The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chemical Research in Toxicology 10(4): 364-368, 1997

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Journal of Neurochemistry 55(3): 870-877, 1990

Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine. Neuroscience Letters 70(2): 255-260, 1986